Herein, we follow the nomenclature proposed by A. Pietrangelo (93), naming the disorder caused by gain-of-function ferroportin mutations “ferroportin hemochromatosis,” and the disorder caused by loss-of-function ferroportin mutations “ferroportin disease.” This evidence concerns the gene SLC40A1 and hemochromatosis type 4.